New York, NY -- (SBWIRE) -- 03/11/2013 -- Pharmathene Inc (NYSEAMEX:PIP) Develops treatments of diseases associated with biological warfare threats. The Company operates as a biodefense company specializing in the development and commercialization of medical countermeasures against chemical and biological threats. PhamAthene's product "Valortim" is a human monoclonal antibody designed to protect against inhalation anthrax, the most lethal form of illness in humans caused by the Bacillus anthracis bacterium.
PIP moved up +10.96% to close at $1.62, extending rally after Aegis Capital launched coverage on the stock with a buy rating a $6 price target. The market value of this company is $78.35million.
It has 73 people in the workforce, over the last 12 months has generated revenue of $25.40 million and has earnings of -$2.90 million. The firm’s operating margin is -23.31 percent and net profit margin -11.42 percent. The latest closing price of its shares moved up +24.71% from the 50-day moving average.
Should PIP Buy PIP After The Recent Movement? Let’s Find out Here
Sequenom Inc (NASDAQ:SQNM) Manufactures DNA detection and sequencing equipment. The Company's two business units combine to utilize their MassARRAY system, SNP assay portfolio, disease gene discovery programs and DNA sample repository. Sequenom provides genetic analysis products that translate genomic science into solutions for biomedical research, molecular medicine and agricultural applications.
Sequenom, Inc. (NASDAQ: SQNM) revealed that, in Miami, FL, at the Loews Miami Hotel in Miami, it will participate in a conference on Wednesday, March 13, 2013, starting at 4:45 p.m. ET, to provide an overview and update of the company. The Director and EVP of Strategic Planning, Ronald M. Lindsay, Ph.D., will present at the Barclays Global Healthcare Conference.
Biotechnology company showing negative movement during previous trade,Sequenom, Inc. (NASDAQ:SQNM) remained among the day losers and traded with volume of9.33 million shares in the last trading session, as compared to average volume of 3.19 million shares.
The stock on Friday decreased -4.01% and finished the day at $4.31. SQNM was a loser in the 5 days activities and slipped about -1.15%. The 52 week range of the stock remained $2.65 – $5.83. The one month performance of the stock was negative and it fell more than -8%.
What Are SQNM’s Charts Signaling for Traders? Find Out Here
Neither PennyStocksUpdate.biz nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by PennyStocksUpdate.biz, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation.PennyStocksUpdate.biz makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through PennyStocksUpdate.biz. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned here in..
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)